ZLAB Zai Lab Limited
$24.14▼ -0.12%
Healthcare
Other
After hours
$24.24▲ +0.41%
Sep 11, 7:30 PM ET
Volume 663.5K
Avg Volume (10D) 841.6K
Key Metrics & Fundamentals
Market Cap
$2.71B
P/E Ratio
–
Div Yield
–%
52W Range
15.96 - 34.72
% vs 50 MA
7.12%
% vs 200 MA
21.19%
RSI-14
47.1
MACD Histogram
-0.4600
Beta (1Y vs SPY)
1.08
Free Cash Flow
-$64.87M
Gross Rev
$106.31M
Gross Profit
$58.15M
EBITDA
-$61.15M
COGS
$48.16M
Operating Exp
$134.64M
Operating Income
-$76.49M
EBIT
-$76.49M
Pretax Income
-$51.85M
Net Income
-$50.83M
EPS (Diluted)
-0.50
Price & Volume History
Loading chart…
Recent News
Zai Lab (ZLAB) Stock Looks Stretched On Sales But Reasonable On Broader Checks
Simply Wall St. · Sep 6, 2026 6:11 PM
Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading
MT Newswires · Sep 4, 2026 2:40 PM
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
MT Newswires · Sep 2, 2026 2:39 PM
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading
MT Newswires · Aug 31, 2026 2:43 PM
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up 2% for Week
MT Newswires · Aug 28, 2026 2:37 PM
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
MT Newswires · Aug 25, 2026 2:44 PM
Could argenx SE (ARGX)’s Global Scale Give it an Edge Over Zai Lab Limited American Depositary Shares (ZLAB)?
Insider Monkey · Aug 20, 2026 10:27 PM
Global DLL3 Targeted Therapies Market 2026-2030: Profiles Amgen, Zai Lab, Boehringer Ingelheim and Phanes Therapeutics
GlobeNewswire · Aug 20, 2026 3:30 PM
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading
MT Newswires · Aug 19, 2026 2:46 PM
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
GlobeNewswire · Aug 18, 2026 7:00 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ZLAB's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.